Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women

This study has been completed.
Procter and Gamble
Information provided by:
Sanofi Identifier:
First received: July 28, 2006
Last updated: December 11, 2009
Last verified: December 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2007
  Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)